Harvesting the wealth of information in biomedical data will advance our understanding of human health and disease, said NIH
Director Francis S.
The MOU establishes a framework to advance the complementary and synergistic goals of CIRM and the NIH
to "help NIH
and CIRM researchers work together to bring their special talents in stem cell and regenerative medicine research to bear upon prevention, diagnosis, and treatment of various diseases.
Roadmap for Medical Research, (1) launched in 2004, is a series of initiatives designed to address fundamental knowledge gaps, develop transformative tools and technologies, and/or foster innovative approaches to complex problems.
Perhaps the most significant is that NIEHS applications have had less favorable review outcomes than applications assigned to most of the other NIH
institutes and centers, in terms of both a larger percentage being "streamlined" (or identified as having less potential for success and therefore afforded a less intensive review process) and a smaller percentage ranking among the highest-scoring 20% of all applications.
The National Assembly of Scientists, an organization representing senior NIH
researchers, has published a statement warning that the rules might produce a brain drain.
With the rapid growth in the public's use of the Internet, the NIH
must take a leadership role in making available to the public the research that we support," says Elias Zerhouni, NIH
From now on, no one at NIH
may accept even unpaid side work with any organization that might have a financial interest in any research or other activity going on at, or supported by, the agency.
proposes that all publications that arise from NIH
-sponsored research be made available free to the public within six months after they have been published.
Combining this expertise with the strength and authority of NIH
and other government and nongovernment organizations, MedlinePlus has become a source of health information to millions of health consumers as well as their health care providers.
A call to the NIH
by The Advocate was not returned, but the agency has said publicly that the purpose of its inquiries to researchers was to gather enough in formation on already-awarded grants to be able to defend them to Congress.
He specifically suggested that a primary focus of the NIH
should be to spend its budget on a cure for Alzheimer's and other chronic diseases.
Prior to the CRADA and during the first 2 years of the agreement, NIH
conducted most of the clinical trials associated with the drug.